Treatment targeting somatostatine receptors in disseminated neuroendocrine tumor — case study

Abstract

Patient age 56 experiencing heartburn and dyspepsia was diagnosed with advanced neuroendocrine tumor via explorative laparotomy. He was treated subsequently with both “hot” (radioactive) and “cold” somatostatine analogues with satisfactory effects — partial control of flush symptom and overall disease stabilization. Following those therapies there was disease progression and classical cytotoxic chemotherapy with 5-fluorouracil, but there were no effect of that type of treatment.